MarketPulse

patent allowance

5 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Allarity Therapeutics

Allarity Therapeutics Secures Patent Allowance for Stenoparib Companion Diagnostic

Allarity Therapeutics received USPTO notice of allowance for stenoparib DRP® companion diagnostic patent, providing exclusivity through 2039.
ALLRPhase 2 clinical trialstenoparib
GlobeNewswire Inc.GlobeNewswire Inc.··Beyond Air, Inc.

Beyond Cancer's UNO Therapy Shows Durable Survival Gains in Early-Stage Cancer Trial

Beyond Cancer presented Phase 1 UNO trial data with six of ten patients alive 22-40 months post-treatment and secured U.S. patent for gas delivery technology.
XAIRbreast cancercancer treatment
BenzingaBenzinga··Prnewswire

Tantech Holdings Secures Patent Allowance for Innovative Cabinet Design

Tantech Holdings secures USPTO patent allowance for hanging cabinet design, strengthening IP portfolio in sustainable residential storage markets.
TANHintellectual propertyUSPTO
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Lightbridge Secures Canadian Patent for Advanced Nuclear Fuel Technology

Lightbridge Corporation received patent approval from Canadian authorities for innovative helically twisted fuel assembly technology applicable to CANDU reactors and small modular reactors.
LTBRsmall modular reactorsintellectual property
BenzingaBenzinga··Prnewswire

Anixa Secures Korean Patent for Breast Cancer Vaccine, Bolstering IP Portfolio

Anixa Biosciences secures patent protection in South Korea for breast cancer vaccine technology, advancing its IP portfolio as Phase 1 trial shows 74% immune response rate.
ANIXintellectual propertyclinical trial